A citation-based method for searching scientific literature

E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
Times Cited: 268







List of co-cited articles
616 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pharmacogenomic information in drug labels: European Medicines Agency perspective.
F Ehmann, L Caneva, K Prasad, M Paulmichl, M Maliepaard, A Llerena, M Ingelman-Sundberg, M Papaluca-Amati. Pharmacogenomics J 2015
76
6

Integrating pharmacogenomics into electronic health records with clinical decision support.
J Kevin Hicks, Henry M Dunnenberger, Karl F Gumpper, Cyrine E Haidar, James M Hoffman. Am J Health Syst Pharm 2016
62
8

Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists.
Katelyn M Alexander, Holly S Divine, Cathy R Hanna, Yevgeniya Gokun, Patricia R Freeman. J Am Pharm Assoc (2003) 2014
31
16


Community pharmacists' experience with pharmacogenetic testing.
Jivan Moaddeb, Rachel Mills, Susanne B Haga. J Am Pharm Assoc (2003) 2015
26
19

Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project".
Peter H O'Donnell, Keith Danahey, Michael Jacobs, Nisha R Wadhwa, Shennin Yuen, Angela Bush, Yasmin Sacro, Matthew J Sorrentino, Mark Siegler, William Harper,[...]. Am J Med Genet C Semin Med Genet 2014
79
6

Framework for development of physician competencies in genomic medicine: report of the Competencies Working Group of the Inter-Society Coordinating Committee for Physician Education in Genomics.
Bruce R Korf, Anna B Berry, Melvin Limson, Ali J Marian, Michael F Murray, P Pearl O'Rourke, Eugene R Passamani, Mary V Relling, John Tooker, Gregory J Tsongalis,[...]. Genet Med 2014
79
6

Healthcare provider education to support integration of pharmacogenomics in practice: the eMERGE Network experience.
Carolyn R Rohrer Vitek, Noura S Abul-Husn, John J Connolly, Andrea L Hartzler, Terrie Kitchner, Josh F Peterson, Luke V Rasmussen, Maureen E Smith, Sarah Stallings, Marc S Williams,[...]. Pharmacogenomics 2017
20
25

Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system.
Keith Danahey, Brittany A Borden, Brian Furner, Patrick Yukman, Sheena Hussain, Donald Saner, Samuel L Volchenboum, Mark J Ratain, Peter H O'Donnell. J Biomed Inform 2017
19
26

Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.
J S Schildcrout, J C Denny, E Bowton, W Gregg, J M Pulley, M A Basford, J D Cowan, H Xu, A H Ramirez, D C Crawford,[...]. Clin Pharmacol Ther 2012
122
5

A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Stephen E Kimmel, Benjamin French, Scott E Kasner, Julie A Johnson, Jeffrey L Anderson, Brian F Gage, Yves D Rosenberg, Charles S Eby, Rosemary A Madigan, Robert B McBane,[...]. N Engl J Med 2013
501
5

Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
Brian F Gage, Anne R Bass, Hannah Lin, Scott C Woller, Scott M Stevens, Noor Al-Hammadi, Juan Li, Tomás Rodríguez, J Philip Miller, Gwendolyn A McMillin,[...]. JAMA 2017
123
5

Transitioning Pharmacogenomics into the Clinical Setting: Training Future Pharmacists.
Amber Frick, Cristina S Benton, Kelly L Scolaro, Jacqueline E McLaughlin, Courtney L Bradley, Oscar T Suzuki, Nan Wang, Tim Wiltshire. Front Pharmacol 2016
18
27

Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network.
Nina R Sperber, Janet S Carpenter, Larisa H Cavallari, Laura J Damschroder, Rhonda M Cooper-DeHoff, Joshua C Denny, Geoffrey S Ginsburg, Yue Guan, Carol R Horowitz, Kenneth D Levy,[...]. BMC Med Genomics 2017
53
9

Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges.
M J Arwood, S Chumnumwat, L H Cavallari, E A Nutescu, J D Duarte. Clin Transl Sci 2016
40
12

Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.
Liza-Marie Johnson, Jessica M Valdez, Emily A Quinn, April D Sykes, Rose B McGee, Regina Nuccio, Stacy J Hines-Dowell, Justin N Baker, Chimene Kesserwan, Kim E Nichols,[...]. Cancer 2017
29
17

Implementing Clinical Pharmacogenomics in the Classroom: Student Pharmacist Impressions of an Educational Intervention Including Personal Genotyping.
Amber Frick, Cristina Benton, Oscar Suzuki, Olivia Dong, Rachel Howard, Hijrah El-Sabae, Tim Wiltshire. Pharmacy (Basel) 2018
9
55

Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.
Dan M Roden, Sara L Van Driest, Jonathan D Mosley, Quinn S Wells, Jamie R Robinson, Joshua C Denny, Josh F Peterson. Clin Pharmacol Ther 2018
46
10


Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?
S J Bielinski, J L St Sauver, J E Olson, M L Wieland, C R Vitek, E J Bell, M E Mc Gree, D J Jacobson, J B McCormick, P Y Takahashi,[...]. Pharmacogenomics J 2017
19
26

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.
Paul A Harris, Robert Taylor, Robert Thielke, Jonathon Payne, Nathaniel Gonzalez, Jose G Conde. J Biomed Inform 2009
5

Pharmacogenetics education in British medical schools.
Jenny E Higgs, Julie Andrews, David Gurwitz, Katherine Payne, William Newman. Genomic Med 2008
32
12

Cytochrome p-450 polymorphisms and response to clopidogrel.
Jessica L Mega, Sandra L Close, Stephen D Wiviott, Lei Shen, Richard D Hockett, John T Brandt, Joseph R Walker, Elliott M Antman, William Macias, Eugene Braunwald,[...]. N Engl J Med 2009
4

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.
Jessica L Mega, Tabassome Simon, Jean-Philippe Collet, Jeffrey L Anderson, Elliott M Antman, Kevin Bliden, Christopher P Cannon, Nicolas Danchin, Betti Giusti, Paul Gurbel,[...]. JAMA 2010
725
4

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.
L H Cavallari, A L Beitelshees, K V Blake, L G Dressler, J D Duarte, A Elsey, J N Eichmeyer, P E Empey, J P Franciosi, J K Hicks,[...]. Clin Transl Sci 2017
48
8

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.
Alan R Shuldiner, Jeffrey R O'Connell, Kevin P Bliden, Amish Gandhi, Kathleen Ryan, Richard B Horenstein, Coleen M Damcott, Ruth Pakyz, Udaya S Tantry, Quince Gibson,[...]. JAMA 2009
4

A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders.
Francis X Brennan, Kathryn R Gardner, Jay Lombard, Roy H Perlis, Maurizio Fava, Herbert W Harris, Rachel Scott. Prim Care Companion CNS Disord 2015
27
14


A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
Joel G Winner, Joseph M Carhart, C Anthony Altar, Josiah D Allen, Bryan M Dechairo. Discov Med 2013
107
4

A new initiative on precision medicine.
Francis S Collins, Harold Varmus. N Engl J Med 2015
4

Using a pharmacogenomic algorithm to guide the treatment of depression.
D K Hall-Flavin, J G Winner, J D Allen, J J Jordan, R S Nesheim, K A Snyder, M S Drews, L L Eisterhold, J M Biernacka, D A Mrazek. Transl Psychiatry 2012
116
4

Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder.
Kimberly Peterson, Eric Dieperink, Johanna Anderson, Erin Boundy, Lauren Ferguson, Mark Helfand. Psychopharmacology (Berl) 2017
32
12


Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
W S Bush, D R Crosslin, A Owusu-Obeng, J Wallace, B Almoguera, M A Basford, S J Bielinski, D S Carrell, J J Connolly, D Crawford,[...]. Clin Pharmacol Ther 2016
95
4

Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
Yuan Ji, Jennifer M Skierka, Joseph H Blommel, Brenda E Moore, Douglas L VanCuyk, Jamie K Bruflat, Lisa M Peterson, Tamra L Veldhuizen, Numrah Fadra, Sandra E Peterson,[...]. J Mol Diagn 2016
90
4

Pharmacogenetics and pharmacogenomics.
M Pirmohamed. Br J Clin Pharmacol 2001
78
5

Implementation of a pharmacogenomics service in a community pharmacy.
Stefanie P Ferreri, Angelo J Greco, Natasha M Michaels, Shanna K O'Connor, Rebecca W Chater, Anthony J Viera, Hawazin Faruki, Howard L McLeod, Mary W Roederer. J Am Pharm Assoc (2003) 2014
52
7

Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.
Susanne B Haga, Nancy M Allen LaPointe, Alex Cho, Shelby D Reed, Rachel Mills, Jivan Moaddeb, Geoffrey S Ginsburg. Pharmacogenomics 2014
23
17

Genomic medicine: a decade of successes, challenges, and opportunities.
Jeanette J McCarthy, Howard L McLeod, Geoffrey S Ginsburg. Sci Transl Med 2013
137
4

Educational innovations in clinical pharmacogenomics.
C G Perry, K A Maloney, A L Beitelshees, Ljb Jeng, N P Ambulos, A R Shuldiner, M G Blitzer. Clin Pharmacol Ther 2016
15
26

Genetics/genomics education for nongenetic health professionals: a systematic literature review.
Divya Talwar, Tung-Sung Tseng, Margaret Foster, Lei Xu, Lei-Shih Chen. Genet Med 2017
38
10




Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis.
Maarten J Deenen, Didier Meulendijks, Annemieke Cats, Marjolein K Sechterberger, Johan L Severens, Henk Boot, Paul H Smits, Hilde Rosing, Caroline M P W Mandigers, Marcel Soesan,[...]. J Clin Oncol 2016
156
4

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.
K A Birdwell, B Decker, J M Barbarino, J F Peterson, C M Stein, W Sadee, D Wang, A A Vinks, Y He, J J Swen,[...]. Clin Pharmacol Ther 2015
267
4

Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.
M V Relling, E E Gardner, W J Sandborn, K Schmiegelow, C-H Pui, S W Yee, C M Stein, M Carrillo, W E Evans, J K Hicks,[...]. Clin Pharmacol Ther 2013
226
4

Prerequisites to implementing a pharmacogenomics program in a large health-care system.
K D Levy, B S Decker, J S Carpenter, D A Flockhart, P R Dexter, Z Desta, T C Skaar. Clin Pharmacol Ther 2014
26
15

Evaluation of a shared pharmacogenomics curriculum for pharmacy students.
Kelly C Lee, Karen Suchanek Hudmon, Joseph D Ma, Grace M Kuo. Pharmacogenomics 2015
26
15

Educational challenges in implementing genomic medicine.
E Passamani. Clin Pharmacol Ther 2013
19
21


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.